Emmanuelle Tavernier

2.4k total citations
73 papers, 1.4k citations indexed

About

Emmanuelle Tavernier is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Emmanuelle Tavernier has authored 73 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 20 papers in Public Health, Environmental and Occupational Health and 17 papers in Oncology. Recurrent topics in Emmanuelle Tavernier's work include Acute Myeloid Leukemia Research (32 papers), Acute Lymphoblastic Leukemia research (20 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Emmanuelle Tavernier is often cited by papers focused on Acute Myeloid Leukemia Research (32 papers), Acute Lymphoblastic Leukemia research (20 papers) and Hematopoietic Stem Cell Transplantation (14 papers). Emmanuelle Tavernier collaborates with scholars based in France, Switzerland and Romania. Emmanuelle Tavernier's co-authors include Xavier Thomas, Hervé Dombret, Denis Guyotat, Jérôme Cornillon, Véronique Lhéritier, Françoise Huguet, Pascale Flandrin‐Gresta, Lydia Campos, Norbert Ifrah and Thibaut Leguay and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Emmanuelle Tavernier

65 papers receiving 1.4k citations

Peers

Countries citing papers authored by Emmanuelle Tavernier

Since Specialization

Citations

This map shows the geographic impact of Emmanuelle Tavernier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Tavernier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Tavernier more than expected).

Fields of papers citing papers by Emmanuelle Tavernier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Tavernier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Tavernier. The network helps show where Emmanuelle Tavernier may publish in the future.

Co-authorship network of co-authors of Emmanuelle Tavernier

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuelle Tavernier. A scholar is included among the top collaborators of Emmanuelle Tavernier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuelle Tavernier. Emmanuelle Tavernier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Management of thrombocytopenia and anticoagulant therapy in patients with hematological malignancy on chemotherapy: a binational prospective study (TAT study) 2025 ·Journal of Thrombosis and Thrombolysis ·(unknown), (unknown), Vasiliki Papadopoulou, Alexis Genthon, (unknown), (unknown), (unknown), Emmanuelle Tavernier, Élisabeth Daguenet, Émilie Chalayer	1
2	Real-World Multicenter Comparison of Venetoclax and Azacitidine Versus Intermediate or High Dose Cytarabine-Based Salvage for Patients with AML in First Relapse after Front Line Intensive Chemotherapy. a Dataml-IPC-Auraml Consortium Study 2024 ·Blood ·(unknown), Sarah Bertoli, (unknown), Maël Heiblig, Thibaut Leguay, Suzanne Tavitian, Éric Delabesse, (unknown), Emmanuelle Tavernier, Martin Carré, (unknown), Anne Banos, Norbert Vey, (unknown), Christian Récher, Sylvain Garciaz	0
3	Azacitidine and Venetoclax As a Salvage Therapy for Relapse after Allogeneic Transplantation for Acute Myeloid Leukemia : A Multicentric Study from French Auraml Group 2024 ·Blood ·Emmanuelle Tavernier, Jérôme Cornillon, (unknown), (unknown), (unknown), Martin Carré, (unknown), (unknown), (unknown), (unknown), (unknown), Sylvain Lamure, Amine Belhabri, Mauricette Michallet, Adrien Contejean, (unknown), Gian Matteo Pica, (unknown), Maël Heiblig	2
4	A 16‐month‐long experience of COVID‐19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM‐TC multicentre cohort study 2023 ·British Journal of Haematology ·Aliénor Xhaard, Constance Xhaard, Marie‐Thérèse Rubio, Ana Berceanu, (unknown), Téreza Coman, Emmanuelle Tavernier, Hélène Labussière‐Wallet, Patrice Chevallier, Faézeh Legrand, (unknown), Anne‐Lise Ménard, Catherine Paillard, Sylvain Chantepie, Marie Robin, Stéphanie Nguyen	3
5	High-Dimensional Mass Cytometry Analysis of Embryonic Antigens and Their Signaling Pathways in Myeloid Cells from Bone Marrow Aspirates in AML Patients at Diagnosis 2023 ·Cancers ·(unknown), Estelle Devêvre, (unknown), Emmanuelle Tavernier, Denis Guyotat, (unknown)	0
6	Utility of 18F-FDG PET/CT in medical care of a promyelocytic sarcoma 2021 ·Current Research in Translational Medicine ·(unknown), Jérôme Cornillon, Pascale Flandrin‐Gresta, (unknown), Nathalie Prévôt, Emmanuelle Tavernier, (unknown)	1
7	Management of bone marrow biopsy related bleeding risks: a retrospective observational study 2021 ·Journal of Thrombosis and Thrombolysis ·(unknown), Martin Killian, Emmanuelle Tavernier, (unknown), Denis Guyotat, Émilie Chalayer	0
8	Sinusoidal obstruction syndrome: a warning about autologous stem cell transplantation preceded by regimens containing oxaliplatin 2020 ·Bone Marrow Transplantation ·(unknown), (unknown), Emmanuelle Tavernier, (unknown), Frédérique Kuhnowski, Jérôme Tamburini, Luc‐Matthieu Fornecker, Vincent Camus, David Sibon, Marie‐Pierre Moles, Sylvie Glaisner, (unknown), Sebastien Mulé, Julien Caldéraro, Daniel Azoulay, Jehane Fadlallah, Corinne Haïoun, Jehan Dupuis	3
9	Dysregulated pathways and differentially expressed proteins associated with adverse transfusion reactions in different types of platelet components 2020 ·Journal of Proteomics ·Chaker Aloui, (unknown), (unknown), (unknown), (unknown), Stéphane Claverol, Emmanuelle Tavernier, Christiane Mounier, Hind Hamzeh‐Cognasse, Fabrice Cognasse, Olivier Garraud, Sandrine Laradi	5
10	Human herpesvirus 6 infection after autologous stem cell transplantation: A multicenter prospective study in adult patients 2019 ·Journal of Infection ·Marie Balsat, Sylvie Pillet, Emmanuelle Tavernier, Victoria Cacheux, Vanessa Escuret, Cécile Moluçon‐Chabrot, Karine Augeul-Meunier, Audrey Mirand, Christel Regagnon, Fabien Tinquaut, (unknown), Mathieu Oriol, Denis Guyotat, Gilles Salles, Jacques‐Olivier Bay, Bruno Pozzetto, Jérôme Cornillon	9
11	Prospective evaluation of systematic use of peripherally inserted central catheters (PICC lines) for the home care after allogeneic hematopoietic stem cells transplantation 2017 ·Supportive Care in Cancer ·Jérôme Cornillon, (unknown), Emmanuelle Tavernier, (unknown), (unknown), (unknown), Alexis Vallard, Karine Augeul-Meunier, (unknown), Denis Guyotat	13
12	An miRNA–DNMT1 Axis Is Involved in Azacitidine Resistance and Predicts Survival in Higher-Risk Myelodysplastic Syndrome and Low Blast Count Acute Myeloid Leukemia 2016 ·Clinical Cancer Research ·(unknown), Catherine Koering, (unknown), Delphine Maucort‐Boulch, Guillaume Robert, Patrick Auberger, Pascale Flandrin‐Gresta, Lionel Adès, Pierre Fenaux, Olivier Kosmider, Emmanuelle Tavernier, Jérôme Cornillon, Denis Guyotat, Lydia Campos, Franck Mortreux, Eric Wattel	29
13	Worsening of Respiratory Status during Neutropenia Recovery in Noncritically Ill Hematological Patients: Results of a Prospective Multicenter Study 2015 ·Respiration ·Marie Balsat, Aliénor Xhaard, Étienne Lengliné, Emmanuelle Tavernier, Jérôme Cornillon, Denis Guyotat, Michaël Darmon	6
14	Impact of fluconazole versus posaconazole prophylaxis on the incidence of fungal infections in patients receiving induction chemotherapy for acute myeloid leukemia 2014 ·Biomedical Journal ·(unknown), H. Rabérin, (unknown), (unknown), (unknown), Jérôme Cornillon, Emmanuelle Tavernier, (unknown), Aurélie Bourmaud	9
15	HSP90 inhibition results in apoptosis of Philadelphia acute lymphoblastic leukaemia cells: an attractive prospect of new targeted agents 2012 ·Journal of Cancer Research and Clinical Oncology ·Emmanuelle Tavernier, Pascale Flandrin‐Gresta, (unknown), (unknown), Jérôme Cornillon, Karine Augeul-Meunier, Jean‐Louis Stephan, (unknown), (unknown), Denis Guyotat, Lydia Campos	4
16	Toxoplasmosis with hemophagocytic syndrome after bone marrow transplantation: diagnosis at autopsy 2008 ·Transplant Infectious Disease ·Sébastien Duband, Jérôme Cornillon, Emmanuelle Tavernier, Jean‐Marc Dumollard, Denis Guyotat, Michel Péoc’h	23
17	Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA‐87 and LALA‐94 trials 2007 ·Cancer ·Emmanuelle Tavernier, Quoc‐Hung Le, Stéphane de Botton, Nathalie Dhédin, Claude‐Eric Bulabois, Oumédaly Reman, Norbert Vey, Véronique Lhéritier, Hervé Dombret, Xavier Thomas	17
18	Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial 2007 ·Leukemia ·Emmanuelle Tavernier, JM Boiron, Françoise Huguet, K. F. Bradstock, Norbert Vey, Tibor Kovacsovics, André Delannoy, Nathalie Fegueux, Pierre Fenaux, Aspasia Stamatoullas, Olivier Tournilhac, Agnès Buzyn, Oumédaly Reman, C Charrin, Claude Boucheix, J Gäbert, Véronique Lhéritier, Vernant Jp, Hervé Dombret, Xavier Thomas	184
19	Kinetics of Chimerism Conversion to Total Donor Profile: Impact on Transplant Outcome after Reduced Intensity Conditioning Allogeneic Transplantation. 2004 ·Blood ·Mauricette Michallet, Quoc‐Hung Le, Anne‐Sophie Michallet, Franck E. Nicolini, Anne Thiébaut, Emmanuelle Tavernier, Hanadi Rafii, (unknown), (unknown), (unknown), (unknown), Valérie Dubois, L. Gebuhrer	1
20	Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors 2003 ·Leukemia Research ·Emmanuelle Tavernier, Quoc‐Hung Le, Mohamed Elhamri, Xavier Thomas	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact